Widespread p53 overexpression in human malignant tumors. An immunohistochemical study using methacarn-fixed, embedded tissue.
about
Detection and monitoring of serum p53 antibodies in patients with colorectal cancer.Detection of p53 and Bcl-2 expression in cutaneous hemangioma through the quantum dot technique.CD44 and p53 immunoexpression patterns in NF1 neoplasms - indicators of malignancy and infiltration.Malignant mixed Mullerian tumors of the uterus: histopathological evaluation of cell cycle and apoptotic regulatory proteins.p53 Protein overexpression in cholangiocarcinoma arising in primary sclerosing cholangitis.Oncogenic role of p53 is suppressed by si-RNA bicistronic construct of uPA, uPAR and cathepsin-B in meningiomas both in vitro and in vivo.Proliferative potential and p53 overexpression in precursor and early stage lesions of bronchioloalveolar lung carcinoma.Assessment of sensitivity and specificity of immunohistochemical staining of p53 in lung and head and neck cancersMarkers for dysplasia of the upper aerodigestive tract. Suprabasal expression of PCNA, p53, and CK19 in alcohol-fixed, embedded tissue.Nuclear p53 protein accumulates preferentially in medullary and high-grade ductal but rarely in lobular breast carcinomasConcurrent p53 expression in bronchial dysplasias and squamous cell lung carcinomas.High levels of p53 protein expression do not correlate with p53 gene mutations in anaplastic large cell lymphomaClinical significance of DNA ploidy and S-phase fraction and their relation to p53 protein, c-erbB-2 protein and HCG in operable muscle-invasive bladder cancer.Hormone resistant prostatic adenocarcinoma. An evaluation of prognostic factors in pre- and post-treatment specimens.p53 immunohistochemistry in transitional cell carcinoma and dysplasia of the urinary bladder correlates with disease progressionProstatic carcinoma: a multivariate analysis of prognostic factors.Mutation of p53 in primary biopsy material and cell lines from Hodgkin disease.Prognostic value of p53 protein expression for patients with gastric cancer--a multivariate analysis.HERG potassium channels are more frequently expressed in human endometrial cancer as compared to non-cancerous endometriumEndometrial carcinoma: immunohistochemically detected proliferation index is a prognosticator of long-term outcome.Clinical importance of p53 protein in gall bladder carcinoma and its precursor lesions.p53 immunoreactivity in cervical intraepithelial neoplasia and non-neoplastic cervical squamous epitheliump53 expression in hepatocellular carcinoma in a population in Singapore with endemic hepatitis B virus infection.Detection of p53 overexpression in routinely paraffin-embedded tissue of human carcinomas using a novel target unmasking fluid.Evaluation of p53 gene expression and prognosis characteristics in uveal melanoma cases.Inducible Nitric Oxide Synthase in the Carcinogenesis of Gastrointestinal Cancers.NDRG4 is a novel oncogenic protein and p53 associated regulator of apoptosis in malignant meningioma cellsp53 expression in lymphatic malignancies.p53 gene product expression in resected non-small cell carcinoma of the lung, with studies of concurrent cytological preparations and microwave antigen retrieval.Tumourigenesis associated with the p53 tumour suppressor gene.p53 expression in Reed-Sternberg cells of Hodgkin's diseaseComparison of p53 gene mutation and protein overexpression in colorectal carcinomasPost-thymic T cell lymphomas frequently overexpress p53 protein but infrequently exhibit p53 gene mutations.
P2860
Q33617886-ACBED02D-F907-42F7-97D3-3E765D0551A9Q33686573-568EA97C-9EB2-40A2-94B9-359285495326Q33962059-5553C010-29A7-41F9-9214-FD890A9984F4Q34035891-16650E3A-6FAE-4FFB-A82D-53CB06464F95Q34409334-A17C7C0E-6B24-408D-BDE1-49CB301D4F27Q34787713-E785FAE0-5009-4DB7-8028-ED3B2F0C3583Q35795011-4867BE60-F409-4135-A626-5B5C7F2B4BACQ35795148-84926BB6-DEB8-427B-8CFD-E5D6460CF026Q35831997-55BFBFCC-D0BA-4CAD-930D-9FDFEDE1CC35Q35832474-4D755648-972C-4BC7-A56F-A81F9163C50EQ35832506-54AA22A4-56EB-43EA-997C-3B202665E56FQ35833598-8A864C27-54B0-4FF1-AB8E-12C8AFE48B5AQ35976630-95125A82-CE2D-4B86-B1B4-C9D00212E613Q35977233-380DFEF3-75FF-4013-A832-61B0977BE90AQ35977771-460633FC-02D4-47A0-B44A-29AD5FBC6532Q35978450-3B422879-1BA2-4A83-B2D1-1D1B10636E84Q36201737-3149F364-15B8-4C6E-928D-F9F3D576714BQ36617448-6BDF8923-52D2-47B5-BB63-32883E7758EAQ36621588-B1D2E6BC-CC7F-481F-9013-7528F839A340Q37215983-0F03DECB-5F0F-4A68-8497-44EFE43DCEECQ37250734-981D6423-9F19-473A-B2D1-04DFFC857A39Q37254159-D8CDF42D-EB06-423F-9D02-0E9E15AA055EQ37258346-15737577-AFD3-48D1-9EE0-6DEFDFBD824FQ38486277-761A5E08-57F2-40EA-B871-206118C0B3B9Q38661387-4902D4BB-3EE3-4A8B-9850-39F0EF26D5D3Q38802590-0AACD0AE-CA7A-4BF6-AF5E-FD457932B13FQ38866385-71212445-B381-451F-86AA-888DF5EEF7BBQ39398079-B14FE8F9-B07D-409C-B0F4-654248CF0F1CQ39566239-B6A0F546-BDC8-4A7C-89B5-779788AF9DF3Q41809596-D783B4FB-49B5-4B81-8C83-499C9FEF92A6Q41906096-A6481D12-D3B6-4FD4-ABBB-4C066B312A38Q42281113-F00C6EBF-A03B-4532-BF59-8CE39E9A18F4Q42754709-7E0E9F84-6534-41F8-AC50-D5C8D5FCB99B
P2860
Widespread p53 overexpression in human malignant tumors. An immunohistochemical study using methacarn-fixed, embedded tissue.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Widespread p53 overexpression ...... hacarn-fixed, embedded tissue.
@ast
Widespread p53 overexpression ...... hacarn-fixed, embedded tissue.
@en
type
label
Widespread p53 overexpression ...... hacarn-fixed, embedded tissue.
@ast
Widespread p53 overexpression ...... hacarn-fixed, embedded tissue.
@en
prefLabel
Widespread p53 overexpression ...... hacarn-fixed, embedded tissue.
@ast
Widespread p53 overexpression ...... hacarn-fixed, embedded tissue.
@en
P2093
P2860
P1476
Widespread p53 overexpression ...... hacarn-fixed, embedded tissue.
@en
P2093
M D Coltrera
P L Porter
P2860
P304
P407
P577
1992-01-01T00:00:00Z